The world's most renowned scientists and physicians will present a wide range of heart rhythm topics including advances in statins, cardiac resynchronization therapy, catheter ablation, cardiac pacing and heart failure, and the latest technology including state-of-the-art pacemakers and defibrillators.
Study highlights include obesity's contribution to risk of sudden cardiac death, electrophysiological characteristics of anger-triggered arrhythmias, and effectiveness of chest thumps to stop fibrillation. Noteworthy late-breaking clinical trials will be unveiled May 7, the meeting's last day.
Dr. Sean Tunis, Chief Medical Officer of the Centers for Medicare and Medicaid Services (CMS), is the invited plenary speaker. A "Town Hall" meeting featuring leaders from the Heart Rhythm Society, CMS, Food and Drug Administration and the National Institutes of Health will also be held.
WHO: The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of over 3,700 physicians and associated professionals in over 65 countries around the world.
Stephen C. Hammill, MD, President of Heart Rhythm Society and Professor of Medicine at the Mayo Medical School and Director, Heart Rhythm Services, Mayo Clinic